Pasithea Therapeutics Corp (KTTA) is down 1.79% Monday In Premarket Trading

Monday, December 06, 2021 08:59 AM | InvestorsObserver Analysts

Mentioned in this article

Pasithea Therapeutics Corp (KTTA) has fallen Monday morning, with the stock falling -1.79% in pre-market trading to 2.75. KTTA's short-term technical score of 19 indicates that the stock has traded less bullishly over the last month than 81% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, Pasithea Therapeutics Corp ranks higher than 39% of stocks. Pasithea Therapeutics Corp has risen 10.67% over the past month, closing at $2.52 on November 8. During this period of time, the stock fell as low as $2.21 and as high as $8.50.

KTTA has an Overall Score of 6. Find out what this means to you and get the rest of the rankings on KTTA!
Pasithea Therapeutics Corp has a Long-Term Technical rank of 0. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 100% of the market scoring higher. In the Biotechnology industry which is number 140 by this metric, KTTA ranks better than 0% of stocks.

Important Dates for Investors in KTTA:

-We do not have a set earnings date for Pasithea Therapeutics Corp at this time. -We do not have a set dividend date for Pasithea Therapeutics Corp at this time. Click Here To Get The Full Report on Pasithea Therapeutics Corp (KTTA)

Share this article: